ZELNORM
Live / Registered — Registered (as of 21 Jan 2020)
What this means for you
Registered since 21 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86555043
- Registration number
- 5967681
- Mark type
- Stylized text
- Filed
- 05 Mar 2015
- Published for opposition
- 11 Oct 2016
- Registered
- 21 Jan 2020
- Attorney of record
- Stephen R. Doody
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of irritable bowel syndrome and constipation
Owner
- ALFASIGMA USA, INC., COVINGTON, LA, US
- ALFASIGMA USA, INC., COVINGTON, LA, US
- SLOAN PHARMA SARL, BERTRANGE BAAR BRANCH, L-8070 BERTRANGE, LU
- SLOAN PHARMA SARL, BERTRANGE BAAR BRANCH, L-8070 BERTRANGE, LU
- Novartis AG, Basel, CH
Prosecution history
- 21 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 18 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Dec 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Dec 2019 — ASSIGNED TO LIE
- 22 Nov 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Nov 2019 — NOTIFICATION OF SU - PRIORITY ACTION E-MAILED
- 18 Nov 2019 — SU - PRIORITY ACTION E-MAILED
- 18 Nov 2019 — SU - PRIORITY ACTION WRITTEN
- 18 Nov 2019 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 08 Nov 2019 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 05 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED